Brinker Capital Investments’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-45,504
Closed -$699K 1426
2021
Q4
$699K Sell
45,504
-7,120
-14% -$93.7K 0.01% 950
2021
Q3
$537K Hold
52,624
0.01% 953
2021
Q2
$537K Buy
52,624
+2,499
+5% +$26.4K 0.01% 1007
2021
Q1
$599K Buy
+50,125
New +$568K 0.01% 863
2020
Q4
Sell
-11,446
Closed -$70K 1239
2020
Q3
$70K Buy
+11,446
New +$87.4K ﹤0.01% 1137

Other funds holding NPTN

Brinker Capital Investments's NPTN Position: Q1 2022 in Review

Brinker Capital Investments sold out of NEOPHOTONICS CORP (NPTN) in Q1 2022, closing a stake of 45,504 shares — an estimated $699K sold.

Brinker Capital Investments first reported a position in NPTN in Q3 2020 and held it in 5 quarters. The position peaked at $699K in Q4 2021. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.

  • Brinker Capital Investments reported no remaining NEOPHOTONICS CORP position as of Q1 2022 after selling out during the quarter.
  • Brinker Capital Investments sold 45,504 NEOPHOTONICS CORP shares in Q1 2022, an estimated $699K.
  • Brinker Capital Investments first reported a position in NEOPHOTONICS CORP in Q3 2020 and held it in 5 quarters.
  • Brinker Capital Investments's NEOPHOTONICS CORP position peaked at $699K in Q4 2021.
  • 143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.

Based on Brinker Capital Investments's 13F filing for Q1 2022, filed 16 May 2022.